Secretary Robert F. Kennedy Jr. said he is considering a “regulatory framework” for Medicare and Medicaid to cover GLP-1 ...

A retrospective study found that women who took a GLP-1 drug for obesity were more likely to be diagnosed with acne vulgaris ...

Current observations and foresight into the world of biosimilars, GLP-1s, PBM and payer trends, according to Jeff Casberg, MS ...

GLP-1 drugs are blockbuster medications for weight loss and Type 2 diabetes. Now doctors are trying them for lymphedema, ...

Two Spoons Creamery is launching its first high-protein ice cream with zero added sugar and GLP-1 compatibility in four ...

Physicians are turning to other options, including older, cheaper medications, as compounding GLP-1s comes to an end.

In a New York Times column this week, the Pennsylvania Democrat shared his experience taking Mounjaro while advocating for ...

Sen. John Fetterman (D-Pa.) on Wednesday called on the Trump administration to back a Biden-era rule that would expand access ...

The infamous gossip blogger is backing the GLP-1 craze, applauding the celebrities who’ve been candid about their weight loss struggles and their experiences with drugs like Ozempic.

A consumer-driven weight loss market could put pharma at greater risk if a recession hits; the continued turmoil at FDA and other HHS agencies magnifies the uncertainty facing the industry; Lilly ...

Senator John Fetterman revealed Tuesday in a piece he penned in The New York Times that he has been using the popular weight ...

The Trump administration is not finalizing a Biden-era provision that would expand coverage of anti-obesity drugs under Medicare and Medicaid, which has disappointed some healthcare leaders.